UpcomingCancerDigestion, Kidneys & Other Organs
Predicting and Preventing treatment related hepatotoxicity to antibody drug conjugate therapy in acute leukaemia
About this grant
This summary is based on the grant title only — the full abstract was not available.
Research project funded by MRF at Imperial College London.
View the original record at the funder ↗
Researchers
Richard Burt (EPMC Awardee)
Related Research
Grants with similar aims, by meaning.
Predicting toxicity and overall survival in patients receiving immunotherapy
RATinG (Risk Adapted Therapy in acute GvHD): Investigating the use of lenzilumab for treating high-risk acute graft versus host disease following allogeneic stem cell transplantation
In vivo analysis of the interactions between acute myeloid leukaemia, T cells and haematopoietic stem cells to inform the design of immunotherapy protocols
Serum interleukin 8 – a predictive biomarker for treatments in patients with advanced hepatocellular carcinoma?
Predicting HLA-specific humoral alloimmunity to improve histocompatibility and immunological risk assessment in transplantation.
Original classification
Impact of Cancer and Cancer Care on Human Biology and Health 2025Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.Is something wrong? Let us know